Chemoinformaics analysis of 2-(4-Methylphenyl)propan-2-ol
| Molecular Weight | 150.221 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 34 |
| Exact Molecular Weight | 150.104 | nRing | 1 |
| Solubility: LogS | -3.988 | nHRing | 0 |
| Solubility: LogP | 5.202 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 1 | BPOL | 14.0449 |
| QED | 0.173 |
| Synth | 3.541 |
| Natural Product Likeliness | 0.341 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.036 |
| HIA | 0.003 |
| CACO-2 | -5.689 |
| MDCK | 0.0000345 |
| BBB | 0.414 |
| PPB | 0.76321 |
| VDSS | 1.369 |
| FU | 0.0581563 |
| CYP1A2-inh | 0.027 |
| CYP1A2-sub | 0.981 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.986 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.63 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.977 |
| CYP3a4-inh | 0.161 |
| CYP3a4-sub | 0.962 |
| CL | 9.951 |
| T12 | 0.423 |
| hERG | 0.994 |
| Ames | 0.076 |
| ROA | 0.167 |
| SkinSen | 0.304 |
| Carcinogencity | 0.027 |
| EI | 0.004 |
| Respiratory | 0.519 |
| NR-Aromatase | 0.507 |
| Antiviral | No |
| Prediction | 0.888641 |